James Investment Research Inc. Sells 4,873 Shares of Axcelis Technologies, Inc. $ACLS

James Investment Research Inc. reduced its stake in shares of Axcelis Technologies, Inc. (NASDAQ:ACLSFree Report) by 58.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,408 shares of the semiconductor company’s stock after selling 4,873 shares during the period. James Investment Research Inc.’s holdings in Axcelis Technologies were worth $317,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Royal Bank of Canada increased its holdings in shares of Axcelis Technologies by 3.8% during the 1st quarter. Royal Bank of Canada now owns 117,566 shares of the semiconductor company’s stock valued at $5,838,000 after acquiring an additional 4,324 shares during the last quarter. AQR Capital Management LLC lifted its holdings in Axcelis Technologies by 4.9% in the 1st quarter. AQR Capital Management LLC now owns 35,717 shares of the semiconductor company’s stock worth $1,774,000 after purchasing an additional 1,678 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Axcelis Technologies by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,396 shares of the semiconductor company’s stock worth $963,000 after purchasing an additional 849 shares during the last quarter. Goldman Sachs Group Inc. boosted its position in Axcelis Technologies by 7.5% during the first quarter. Goldman Sachs Group Inc. now owns 635,393 shares of the semiconductor company’s stock worth $31,560,000 after purchasing an additional 44,275 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in Axcelis Technologies by 1.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 78,756 shares of the semiconductor company’s stock worth $3,912,000 after purchasing an additional 836 shares during the period. Institutional investors and hedge funds own 89.98% of the company’s stock.

Axcelis Technologies Stock Performance

NASDAQ ACLS opened at $144.50 on Friday. Axcelis Technologies, Inc. has a 52-week low of $65.64 and a 52-week high of $193.78. The company has a debt-to-equity ratio of 0.04, a current ratio of 4.59 and a quick ratio of 2.99. The firm has a market capitalization of $4.44 billion, a price-to-earnings ratio of 45.02, a P/E/G ratio of 12.63 and a beta of 1.88. The company’s fifty day moving average is $160.64 and its two-hundred day moving average is $115.68.

Axcelis Technologies (NASDAQ:ACLSGet Free Report) last announced its quarterly earnings results on Thursday, May 7th. The semiconductor company reported $0.72 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.71 by $0.01. The firm had revenue of $198.96 million for the quarter, compared to analyst estimates of $195.03 million. Axcelis Technologies had a net margin of 11.93% and a return on equity of 12.19%. The business’s revenue for the quarter was up 3.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.88 EPS. Axcelis Technologies has set its Q2 2026 guidance at 0.900- EPS. Equities research analysts forecast that Axcelis Technologies, Inc. will post 3.21 EPS for the current year.

Insiders Place Their Bets

In other news, EVP Gerald M. Blumenstock sold 1,161 shares of the company’s stock in a transaction that occurred on Thursday, May 21st. The stock was sold at an average price of $152.70, for a total value of $177,284.70. Following the sale, the executive vice president directly owned 20,493 shares in the company, valued at approximately $3,129,281.10. This represents a 5.36% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, EVP Christopher Tatnall sold 1,166 shares of the company’s stock in a transaction that occurred on Wednesday, May 20th. The shares were sold at an average price of $149.75, for a total value of $174,608.50. Following the completion of the sale, the executive vice president owned 27,627 shares in the company, valued at approximately $4,137,143.25. This represents a 4.05% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 34,795 shares of company stock valued at $5,344,383 over the last 90 days. Company insiders own 0.49% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on ACLS shares. Bank of America lifted their price target on shares of Axcelis Technologies from $130.00 to $156.00 and gave the company an “underperform” rating in a research report on Tuesday, June 23rd. Weiss Ratings lowered shares of Axcelis Technologies from a “hold (c)” rating to a “hold (c-)” rating in a research note on Tuesday, May 12th. Zacks Research upgraded shares of Axcelis Technologies from a “strong sell” rating to a “hold” rating in a report on Monday, April 20th. Finally, B. Riley Financial raised shares of Axcelis Technologies from a “neutral” rating to a “buy” rating and set a $150.00 target price for the company in a research report on Monday, April 20th. Three equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Axcelis Technologies has an average rating of “Hold” and an average price target of $130.25.

Read Our Latest Research Report on Axcelis Technologies

Axcelis Technologies Company Profile

(Free Report)

Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.

The company’s product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.

Read More

Want to see what other hedge funds are holding ACLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axcelis Technologies, Inc. (NASDAQ:ACLSFree Report).

Institutional Ownership by Quarter for Axcelis Technologies (NASDAQ:ACLS)

Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.